Sildenafil Citrate Tablet
Product Images NDC 50090-7181

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 50090-7181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907181)

SILDENAFIL CITRATE 50 mg oral tablets label from A-S Medication Solutions. The label indicates each tablet contains 50 mg of sildenafil citrate and comes in a package of 10 tablets. Storage instructions specify to store at 77 degrees Fahrenheit.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

A line graph depicting the mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers, comparing sildenafil 100 mg and placebo. The x-axis represents time post-dose in hours, and the y-axis shows systolic blood pressure change in mmHg.*

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing blood pressure changes over 8 hours postdose. It compares two groups: Doxazosin + Placebo (blue line) and Doxazosin + Sildenafil 25 mg (black line), plotting mean blood pressure change in mmHg on the y-axis against time postdose in hours on the x-axis.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

A line graph showing mean standing systolic blood pressure change from baseline over 8 hours postdose, comparing Doxazosin + Placebo versus Doxazosin + Sildenafil 50 mg. The vertical axis shows change in SBP (mmHg), and the horizontal axis shows time in hours postdose. The data points show variations over time with two distinct lines for each treatment group.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

A line graph depicting the mean change in standing systolic blood pressure from baseline over an 8-hour period after dosing. The x-axis represents time after dosing in hours, and the y-axis shows blood pressure change in mmHg. Two lines compare effects of Doxazosin with Sildenafil 100 mg versus Doxazosin with placebo.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

A line graph titled 'Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers,' showing plasma concentration (ng/mL) over time post dose (hours). The graph compares sildenafil plasma levels after treatment with a commercial tablet, with concentration peaking early and declining over time.*

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

Two bar charts comparing the effect of sildenafil citrate and placebo on maintenance of erection by baseline score. The x-axis shows baseline scores from 0 to 5, while the y-axis represents the percentage of patients at endpoint, ranging from 0% to 80%. Different bars correspond to scores 0 through 5, visually illustrating patient response distributions for each treatment group.*

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

A bar chart showing the percentage of patients reporting improvement across different treatment groups. The groups include Placebo, Sildenafil citrate 25 mg, Sildenafil citrate 50 mg, and Sildenafil citrate 100 mg, with percentages increasing from 24% for Placebo to 82% for Sildenafil citrate 100 mg. The X-axis represents treatment groups, and the Y-axis represents the percentage of patients reporting improvement.*

FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

Chemical structure diagram of sildenafil citrate, illustrating the molecular composition of the active ingredient in the 50 mg oral tablet form by A-S Medication Solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.